Abstract
Ponesimod (PONVORY (TM)) is an orally administered selective sphingosine-1-phosphate (S1P) receptor 1 (S1P(1)) agonist being developed by the Janssen ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
